Continued from page 7.
(94) Boutin C, Rey F, Gouvernet J, et al. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients; part 2. Prognosis and staging. Cancer 1993; 72:394-404
(95) Wilsher ML, Veale AG. Medical thoracoscopy in the diagnosis of unexplained pleural effusion. Respirology 1998; 3:77-80
(96) Kamp DW, Mossman BT. Asbestosis associated cancers: clinical spectrum and pathogenic mechanisms. Clin Occup Environ Med 2002; 2:753-757
(97) Shrager JSD, Kaiser L. Surgery and staging of mesothelioma. London, UK: Martin Dunitz, 2002
(98) Zellos LS, Sugarbaker DJ. Multimodality treatment of diffuse malignant pleural mesothelioma. Strain Oncol 2002; 29:41-50
(99) Shukula A, Her T, Kamp DW, et al. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med 2003; 34:1117-1129
(100) Roberts GH. The pathology of parietal pleural plaques. J Clin Pathol 1971; 24:348-353
(101) Bateman ED, Benatar SR. Asbestos-induced diseases: clinical perspectives, QJ Med 1987; 62:183-194
(102) Sahn SA, Antony VB. Pathogenesis of pleural plaques: relationship of early cellular response and pathology. Am Rev Respir Dis 1984; 130:884-887
(103) Kamp DW, Weitzman SA. The molecular basis of asbestos induced lung injury. Thorax 1999; 54:638-652
(104) Quinlan TR, BeruBe KA, Hacker MP, et al. Mechanisms of asbestos-induced nitric oxide production by rat alveolar macrophages in inhalation and in vitro models. Free Radic Biol Med 1998; 24:778-788
(105) Chao CC, Park SH, Aust AE. Participation of nitric oxide and iron in the oxidation of DNA in asbestos-treated human lung epithelial cells. Arch Biochem Biophys 1996; 326:152-157
(106) Jaurand MC. Mechanisms of fiber-induced genotoxicity. Environ Health Perspect 1997; 105:1073-1084
(107) Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nature Cell Biol 2001; 3:E255-E263
(108) Bortner CD, Cidlowski JA. Cellular mechanisms for the repression of apoptosis. Annu Rev Pharmacol Toxicol 2002; 42:259-281
(109) BeruBe KA, Quinlan TR, Fung H, et al. Apoptosis is observed in mesothelial cells after exposure to crocidolite asbestos. Am J Respir Cell Mol Biol 1996; 15:141-147
(110) Broaddus VC, Yang L. Seavo LM, et al. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J Clin Invest 1996; 98:2050-2059
(111) Hoidal JR. Reactive oxygen species and cell signaling. Am J Respir Cell Mol Biol 2001; 25:661-663
(112) Vaslet VA, Messier NJ, Kane AB. Accelerated progression of asbestos-associated mesotheliomas in heterozygous [p53.sup.+/-] mice. Toxicol Sci 2902; 68:331-338
(113) Heintz NH, Janssen YM, Mossman BT. Persistent induction of c-fos and c-jun expression by asbestos. Proc Natl Acad Sci U S A 1993; 90:3299-3303
(114) Reilly W. Environmental quality: responses from industry and government; is environmental quality good for business? Washington, DC: American Enterprise Institute for Public Policy Research, 1990
(115) Krump KS. Letter to the editor. Science 1990; 248:799
(116) Cordier S, Lazar P, Brochard P, et al. Epidemiologic investigation of respiratory effects related to environmental exposure to asbestos inside insulated buildings. Arch Environ Health 1987; 42:303-309
(117) Schwartz VE, Lorber L. A letter to the nation's trial judges: how the focus on efficiency is hurting you and innocent victims in asbestos liability cases. Am J Trial Advocacy 2000; 24:24 247-268
(118) Mitchell RS, Chase GR, Kotin PI. Evaluation for compensation of asbestos-exposed individuals. J Occup Med 1985; 27:95-109
(119) Cocchiarella L, Anderson G. Guides to the evaluation of permanent impairment. 5th ed. Chicago. IL: American Medical Association, 2001
(120) American Bar Association. Commission on Asbestos Litigation, Chicago, December 18-19, 2002
* From the Feinberg School of Medicine, Division of Respiratory and Critical Care Medicine, Northwestern University and The Veterans Administration Chicago Health Care System, Lakeside Division, Chicago, IL.
Supported in part by Veterans Administration Merit Award (Dr. Kamp).
Manuscript received October 10, 2002; revision accepted July 17, 2003.
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (e-mail: permissions@chestnet.org).
Correspondence to: David W. Cugell, MD, FCCP, Rehabilitation Institute, 345 E Superior St, Room 354, Chicago, IL 60611; e-mail: mymble@northwestern.edu
COPYRIGHT 2004 American College of Chest Physicians
COPYRIGHT 2004 Gale Group
Start Of Article
« Previous 1 2 3 4 5 6 7 8 
